Blue Cross Blue Shield Oklahoma policies, page 2

Search Blue Cross Blue Shield Oklahoma's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

534 public policies Substrate tracks for Blue Cross Blue Shield Oklahoma, by title.

Blue Cross Blue Shield Oklahoma policies
PolicyDetailsCodesSource
Biofeedback for Miscellaneous IndicationsPSY301.007 · Effective Jan 1, 2026 · Commercial, Medicaid4Original policy ↗
Bioimpedance Devices for Detection and Management of LymphedemaMED201.036 · Effective Oct 15, 2025 · Commercial, Medicaid1Original policy ↗
Biomarker Testing for Autoimmune Rheumatic DiseaseRPLAB011 · Effective Sep 4, 2026 · Commercial, Medicaid · OK18Original policy ↗
Biomarker Testing for Multiple Sclerosis and Related Neurologic DiseasesCPCPLAB036 · Effective Jan 3, 2026 · Commercial, Medicaid · OK12Original policy ↗
Biomarker Testing in Risk Assessment and Management of Cardiovascular DiseaseMED207.008 · Commercial, Medicaid25Original policy ↗
Biomarkers for Myocardial Infarction and Chronic Heart FailureCPCPLAB046 · Effective Nov 7, 2025 · Commercial, Medicaid · OK18Original policy ↗
Biomarkers for Myocardial Infarction and Chronic Heart FailureRPLAB046 · Effective Dec 4, 2026 · Commercial, Medicaid · OK18Original policy ↗
Biventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart FailureMED202.054 · Commercial, Medicaid48Original policy ↗
Blepharoplasty and BlepharoptosisSUR716.004 · Commercial, Medicaid25Original policy ↗
BlueCard®Program Provider ManualCommercial, Medicaid · OK—Original policy ↗
Bone Morphogenetic ProteinSUR705.038 · Commercial, Medicaid3Original policy ↗
Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone TurnoverMED207.116 · Commercial, Medicaid3Original policy ↗
Botulinum ToxinRX501.019 · Effective Jan 1, 2026 · Commercial, Medicaid28Original policy ↗
Brolucizumab-dbllOTH903.043 · Effective Sep 15, 2026 · Commercial, Medicaid2Original policy ↗
Bronchial ThermoplastySUR706.014 · Effective Dec 15, 2025 · Commercial, Medicaid2Original policy ↗
Bronchial ValvesSUR706.015 · Commercial, Medicaid4Original policy ↗
Burosumab-twzaRX502.058 · Commercial, Medicaid1Original policy ↗
CanakinumabRX501.119 · Effective Apr 15, 2026 · Commercial, Medicaid1Original policy ↗
Cardiac Applications of Positron Emission Tomography ScanningRAD605.001 · Commercial, Medicaid13Original policy ↗
Cardiac Contractility Modulation DeviceMED202.068 · Commercial, Medicaid32Original policy ↗
Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient SettingMED202.058 · Effective Jan 1, 2026 · Commercial, Medicaid7Original policy ↗
Cardiac Rehabilitation in the Outpatient SettingTHE803.023 · Effective Sep 15, 2026 · Commercial, Medicaid5Original policy ↗
Cardiovascular Disease Risk AssessmentRPLAB020 · Effective Sep 4, 2026 · Commercial, Medicaid · OK50Original policy ↗
Category III Current Procedural Terminology (CPT®) CodesADM1001.035 · Effective Jul 1, 2026 · Commercial, Medicaid517Original policy ↗
Celiac Disease TestingCPCPLAB017 · Effective Jan 3, 2026 · Commercial, Medicaid · OK12Original policy ↗
Cerliponase alfaRX501.092 · Commercial, Medicaid1Original policy ↗
Certolizumab PegolRX501.111 · Commercial, Medicaid1Original policy ↗
Cervical Cancer ScreeningCPCPLAB002 · Effective Jan 3, 2026 · Commercial, Medicaid · OK32Original policy ↗
Chelation Therapy for Off-Label UsesTHE801.008 · Commercial, Medicaid9Original policy ↗
Chemical PeelsSUR716.018 · Effective Sep 1, 2026 · Commercial, Medicaid5Original policy ↗
Children Wellness Guidelines71440.0925 · Commercial, Medicaid · OK—Original policy ↗
Children Wellness Guidelines (Spanish)71559.0925 · Commercial, Medicaid · OK—Original policy ↗
Chiropractic Care ServicesRP016 · Effective Jul 24, 2026 · Commercial, Medicaid · OK4Original policy ↗
Chromoendoscopy as an Adjunct to ColonoscopyMED201.022 · Commercial, Medicaid2Original policy ↗
Clinical Trial Treatment or TherapyADM1001.027 · Commercial, Medicaid13Original policy ↗
Closure Devices for Patent Foramen Ovale and Atrial Septal DefectsSUR707.024 · Commercial, Medicaid2Original policy ↗
Co-Surgeon/Team Surgeon Policy – Professional ProviderRP009 · Effective Apr 10, 2026 · Commercial, Medicaid · OK—Original policy ↗
Cochlear ImplantSUR714.004 · Effective Jan 1, 2026 · Commercial, Medicaid20Original policy ↗
Cognitive RehabilitationTHE803.019 · Effective Jan 1, 2026 · Commercial, Medicaid3Original policy ↗
Collection and Storage of Umbilical Cord Blood Stem CellsSUR703.058 · Commercial, Medicaid5Original policy ↗
Colorectal Cancer ScreeningRPLAB071 · Effective Sep 4, 2026 · Commercial, Medicaid · OK11Original policy ↗
Colorectal Cancer ScreeningRPLAB071 · Effective Dec 4, 2026 · Commercial, Medicaid · OK12Original policy ↗
Composite Tissue Allotransplantation of the Hand and FaceSUR703.052 · Commercial, Medicaid1Original policy ↗
Compression Pumps for Treatment of Lymphedema and Venous UlcersMED202.060 · Commercial, Medicaid33Original policy ↗
Computed Tomography to Detect Coronary Artery CalcificationRAD604.009 · Commercial, Medicaid10Original policy ↗
Computer-Assisted Navigation for Orthopedic ProceduresSUR705.023 · Effective Sep 1, 2026 · Commercial, Medicaid3Original policy ↗
Confocal Laser Endomicroscopy (CLE)MED201.038 · Commercial, Medicaid4Original policy ↗
Continuous Passive Motion in the Home SettingDME101.023 · Commercial, Medicaid3Original policy ↗
Corneal Collagen Cross-LinkingOTH903.028 · Commercial, Medicaid5Original policy ↗
Corneal HysteresisOTH903.031 · Commercial, Medicaid1Original policy ↗

Back to Blue Cross Blue Shield Oklahoma · Blue Cross Blue Shield Oklahoma prior authorization CPT list

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.